¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"linear electric field effect"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • palliative effect
    ¿ÏÈ­È¿°ú, °æ°¨È¿°ú
  • rush effect
    ¼âµµÈ¿°ú
  • radiation effect
    ¹æ»ç¼±È¿°ú
  • resonance effect
    °ø¸íÈ¿°ú
  • radioactive effect
    ¹æ»ç´ÉÈ¿°ú
  • reversing effect
    ¿ªÀüÈ¿°ú
  • spin phase effect
    ½ºÇÉÀ§»óÈ¿°ú
  • stochastic effect
    È®·üÈ¿°ú
  • suction effect
    Èí¼öÈ¿°ú
  • summation effect
    °¡ÁßÈ¿°ú
  • synergistic effect
    »ó½ÂÈ¿°ú
  • shielding effect
    Â÷ÆóÈ¿°ú, °¡¸²È¿°ú
  • shunt effect
    Áö¸§±æÈ¿°ú, ¼ÇƮȿ°ú
  • side effect
    ºÎÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • healthy worker effect
    °Ç°­±Ù·ÎÀÚÈ¿°ú
  • in-flow effect
    À¯ÀÔÈ¿°ú
  • indifferent effect
    ¹«°ü½ÉÀÛ¿ë
  • inhibitory effect
    ¾ïÁ¦È¿°ú
  • inotropic effect
    ¼öÃàÃËÁøÈ¿°ú
  • isotopic effect
    µ¿À§¿ø¼ÒÈ¿°ú
  • late effect
    ¸¸±âÈ¿°ú, ÈÄÀ¯È¿°ú
  • latitude effect
    À§µµÈ¿°ú
  • magnetization transfer effect
    ÀÚ±âÈ­Àü´ÞÈ¿°ú
  • masking effect
    ÀºÆóÈ¿°ú
  • mass effect
    µ¢ÀÌÈ¿°ú
  • mesomeric effect
    °ø¸íÈ¿°ú
  • nonstochastic effect
    ºñÈ®·ü·ÐÀûÈ¿°ú
  • nonthermal effect
    ºñ¿­È¿°ú
  • oblique angle effect
    »ç°¢È¿°ú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • field flattening filter
    Á¶»ç¿µ¿ª ÆíÆòÈ­¿©°ú±â
  • field gradient
    ÀÚÀå °æ»ç
  • field inhomogeneity
    ÀÚÀå ºÒ±ÕÀÏ(¼º)
  • field of Cohnheim
  • field of Forel
  • field of cornu ammonis
  • field of fixation
    Áֽýþß
  • field of gaze
    Áֽþȿ¹üÀ§
  • field of view
    ½Ã¾ß (ãÊå¯)
  • field of view (FOV)
    ¿µ»ó ¿µ¿ª, ¿µ»ó ¹üÀ§
  • field of vision
    ½Ã¾ß
  • field seperation
    Á¶»ç¿µ¿ªºÐ¸®
  • field size
    Á¶»ç¿µ¿ªÅ©±â
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
  • field supervisor
    ÇöÁöÁöµµ¿ø.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
AEF allogenic effect factor; amyloid enhancing factor; aorto-enteric fistula
CE California encephalitis; cardiac enlargement; cardioesophageal; carotid endarterectomy; catamenial e...
CPE cardiac pulmonary edema; chronic pulmonary emphysema; clinical progress exercise; compensation, pens...
CRE cumulative radiation effect; cyclic adenosine monophosphate-response element
DEF decayed primary teeth requiring filling, decayed primary teeth requiring extraction, and primary tee...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
LOAEL Lowest Observed Adverse Effect Level
LOEL Lowest Observed Effect Level
LOEC Lowest observed effect concentrations
ME McCollough Effect
NOAEL No Observable Adverse Effect Level
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • T1 shortening effect
    T1 ´ÜÃà È¿°ú
  • teratogenic effect
    ÃÖ±â ÀÛ¿ë, ÃÖ±âÇü ÀÛ¿ë
  • toxic effect curve
    µ¶¼º °î¼±
  • training effect
    ÈÆ·Ã È¿°ú
  • Tyndall effect
    Tyndall È¿°ú
    ÀÛÀº ÄÝ·ÎÀ̵å ÀÔÀÚ´Â ´«¿¡ º¸ÀÌÁö ¾ÊÁö¸¸ ÀÔÀÚµéÀÌ ºûÀ» »ê¶õ½ÃŰ¹Ç·Î Á÷°¢ ¹æÇâ¿¡¼­ °üÂûÇÏ¸é ºûÀÇ Áø·Î¸¦ °üÂû ÇÒ ¼ö ÀÖ´Â °Í.
  • untoward drug effect
    ¾à¹°ÀÇ ¹Ù¶÷Á÷ÇÏÁö ¾Ê´Â È¿°ú
    ¿ì¸®°¡ ¿øÇÏ´Â Ä¡·á ¸ñÀû¿¡ ºÎÇÕÇÏ´Â ¾à¸® ÀÛ¿ëÀÌ ¾Æ´Ï¶ó ÀÎü¿¡ ÇØ°¡µÇ´Â µ¶ ÀÛ¿ë ¶Ç´Â ºÎÀÛ¿ë.
  • waveguide effect
    µµÆÄ°ü È¿°ú
  • Zeeman effect
    Á¦¸¸ È¿°ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
cytopathogenic effect, viral Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is cell transformation, viral. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses.
(12 Dec 1998)
healthy worker effect Phenomenon of workers' usually exhibiting overall death rates lower than those of the general population due to the fact that the severely ill and disabled are ordinarily excluded from employment.
(12 Dec 1998)
second gas effect When a constant concentration of an anaesthetic like halothane is inspired, the increase in alveolar concentration is accelerated by concomitant administration of nitrous oxide, because alveolar uptake of the latter creates a potential subatmospheric intrapulmonary pressure that leads to increased tracheal inflow.
(05 Mar 2000)
homotropic effect An effect where two identical ligands (small molecules) allosterically interact with each other.
(09 Oct 1997)
Purkinje effect <ophthalmology> In the light-adapted eye, the region of maximal brightness is in the yellow; in the dark-adapted eye, the region of maximal brightness is in the green.
Synonym: Purkinje effect, Purkinje shift.
(05 Mar 2000)
hydrophobic effect <chemistry> The tendency for the nonpolar portions of a group of lipid molecules to clump together with one another and exclude water and other polar molecules. The polar portions of the lipid molecules end up facing out. The hydrophobic effect is primarily responsible for the construction of lipid bilayers.
(09 Oct 1997)
side effect <pharmacology> A consequence other than the one for which an agent or measure is used, as the adverse effects produced by a drug, especially on a tissue or organ system other than the one sought to be benefited by its administration.
For example: hair loss may be a side effect of chemotherapy, fatigue may be a side effect of radiation therapy.
(14 Oct 1997)
hyperchromic effect An increase in absorptivity (or extinction) at a particular wavelength of light by a solution or substance due to structural changes in a molecule.
(05 Mar 2000)
sigma effect The decrease in apparent viscosity that occurs when a suspension, such as blood, is made to flow through a tube of smaller diameter; observed in tubes less than about 0.3 mm in diameter.
Synonym: sigma effect.
(05 Mar 2000)
hypochromic effect A phenomenon in which an individual molecule, containing several chromophores, has a certain absorptivity (or optical density) at a given wavelength that is less than the sum of the optical densities of the individual chromophores (at that same wavelength).
(05 Mar 2000)
Somogyi effect In diabetes, a rebound phenomenon of reactive hyperglycaemia in response to a preceding period of relative hypoglycaemia that has increased secretion of hyperglycaemic agents (epinephrine, norepinephrine, glucagon, cortisol, and growth hormone); described in diabetic patients given too much insulin who developed unrecognised nocturnal hypoglycaemia that made them hyperglycaemic (suggesting insufficient insulin) when tested the next morning.
(05 Mar 2000)
stark effect <radiobiology> The effect an electric field has on the spectral lines emitted from excited atoms.
The effect may arise from externally-applied electric fields, from internal fields due to the presence of neighboring ions or atoms (pressure), or from the electric field associated with the Lorentz (v cross B) force (motional stark effect). Spectroscopic measurements of plasmas using the pressure-based and motional Stark effects are useful for diagnostic purposes.
(09 Oct 1997)
Staub-Traugott effect In normal persons, a drop in blood glucose which follows a second oral dose of glucose given 30 minutes or so after the first.
(05 Mar 2000)
Stiles-Crawford effect Light that enters through the centre of the pupil produces a greater visual effect than light that enters obliquely.
(05 Mar 2000)
no-observed-adverse-effect level The highest dosage administered that does not produce toxic effects. The noael will depend on how closely dosages are spaced (lowest-observed-adverse-effect level and no-observed-effect level) and the number of animals examined. The ultimate objective is usually to determine not the "safe" dosage in laboratory animals but the "safe" dosage for humans. Therefore, the extrapolation most often required of toxicologists is from high-dosage studies in laboratory animals to low doses in humans. (casarett and doull's toxicology: the basic science of poisons, 4th ed)
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á